Amyra

Basel, Switzerland Founded: 2013 • Age: 13 yrs
Pioneers enzyme supplementation for general health, nutrition, and food sensitivities.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors 7 Brand Intelligence

About Amyra

Amyra is a company based in Basel (Switzerland) founded in 2013. It operates as a D2C. Amyra offers products and services including BBEST. Amyra operates in a competitive market with competitors including Palisade Bio, CJ HealthCare, EsoCap Biotech, Nucliqbio and Carbiotix, among others.

  • Headquarter Basel, Switzerland
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Nutrition, Wellness & Lifestyle Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Amyra

Amyra offers a comprehensive portfolio of products and services, including BBEST.

Product name locked
Category locked
Primary

Provides enzyme supplementation for health and nutrition issues.

Funding Insights of Amyra

Premium access

Detailed funding history for Amyra

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Amyra

Investments
Premium access

Investment portfolio details for Amyra

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Amyra

Premium access

Detailed financials for Amyra

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Amyra Comparisons

Amyra Primary company
Description
Pioneers enzyme supplementation for general health, nutritio...
Location
Basel, Switzerland
Founded Year
2013
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Amyra

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Amyra

Amyra operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Palisade Bio, CJ HealthCare, EsoCap Biotech, Nucliqbio and Carbiotix, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Therapeutics for gastrointestinal complications are developed by Palisade Bio.
Locked Locked Locked
Developer of therapies for treating gastrointestinal disorders
Locked Locked Locked
Topical drug delivery platform for upper GI disorders is developed.
Locked Locked Locked
Therapeutic drugs for gut health are developed using metagenomics.
Locked Locked Locked
Prebiotic ingredients and consumer products for microbiome health are developed.
Premium access

Detailed competitors of Amyra

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Amyra

Premium access

Complete news archive for Amyra

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amyra

Amyra was founded in 2013.

Amyra is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.

AMYRA Biotech focuses on innovating Brush Border Enzyme Supplementation Technology (BBEST) to tackle health challenges like nutrition deficiencies, food sensitivities, and gastrointestinal diseases through enzyme-based solutions. The company conducts research on brush border membrane enzymes in the small intestine and their roles in disease and nutrition. Based on implied activities, they offer supplementation products and literature reviews, potentially serving health professionals and consumers worldwide.

Amyra's top competitors include Palisade Bio, Carbiotix and EsoCap Biotech.

Amyra offers BBEST.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available